CHIRON PHARMASYNTH AS

7041 TRONDHEIM

Finances

Share Ownership

Return on Equity

10,27 %

Current Ratio

2,62

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	15 919 000	10 926 000	11 031 000	10 978 000
Net Income	1 806 000	3 292 000	4 440 000	3 421 000
Total Assets	28 458 000	25 541 000	21 661 000	16 811 000
Total Equity	17 578 000	15 772 000	14 439 000	11 791 000

Income (NOK)	2022	2021	2020	2019
Revenue	15 919 000	10 926 000	11 031 000	10 978 000
Expenditure	14 272 000	7 091 000	6 356 000	7 688 000
Operating Profit	1 647 000	3 836 000	4 675 000	3 290 000
Financial Income	369 000	143 000	400 000	160 000
Financial Costs	124 000	134 000	130 000	28 000
Financial Balance	245 000	9 000	270 000	132 000
Earnings Before Tax	1 893 000	3 845 000	4 946 000	3 421 000
Tax	87 000	552 000	506 000	0
Net Income	1 806 000	3 292 000	4 440 000	3 421 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	14 000	30 000
Total Current Assets	28 458 000	25 541 000	21 647 000	16 781 000
Total Assets	28 458 000	25 541 000	21 661 000	16 811 000
Total Retained Equity	15 803 000	13 997 000	12 664 000	10 016 000
Total Equity	17 578 000	15 772 000	14 439 000	11 791 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	10 880 000	9 769 000	7 222 000	5 021 000
Total Equity and Debt	28 458 000	25 541 000	21 661 000	16 811 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	14 710 000	9 316 000	9 313 000	10 476 000
Other Income	1 210 000	1 611 000	1 718 000	502 000
Revenue	15 919 000	10 926 000	11 031 000	10 978 000
Cost of Goods Sold	2 316 000	710 000	814 000	1 439 000
Salary Costs	8 269 000	4 233 000	3 557 000	3 327 000
Depreciation	0	14 000	16 000	19 000
Impairment	0	0	0	0
Expenditure	14 272 000	7 091 000	6 356 000	7 688 000
Operating Profit	1 647 000	3 836 000	4 675 000	3 290 000
Financial Income	369 000	143 000	400 000	160 000
Financial Costs	124 000	134 000	130 000	28 000
Financial Balance	245 000	9 000	270 000	132 000
Dividends	0	0	0	0
Net Income	1 806 000	3 292 000	4 440 000	3 421 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	14 000	30 000
Fixtures	0	0	0	0
Total Tangible Assets	0	0	14 000	30 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	14 000	30 000
Stock	2 402 000	2 118 000	1 755 000	1 649 000
Total Investments	0	0	0	0
Cash, Bank	359 000	167 000	172 000	143 000
Total Current Assets	28 458 000	25 541 000	21 647 000	16 781 000
Total Assets	28 458 000	25 541 000	21 661 000	16 811 000
Total Equity	17 578 000	15 772 000	14 439 000	11 791 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	213 000	25 000	0	34 000
Unpaid Taxes	151 000	125 000	118 000	114 000
Dividends	0	0	0	0
Other Current Debt	10 428 000	9 619 000	7 104 000	4 873 000
Total Current Debt	10 880 000	9 769 000	7 222 000	5 021 000
Total Equity and Debt	28 458 000	25 541 000	21 661 000	16 811 000

Financial indicators	2022	2021	2020	2019
Return on Equity	10,27 %	20,87 %	30,75 %	29,01 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	10,35 %	35,11 %	42,38 %	29,97 %
Current Ratio	2,62	2,61	3	3,34
Quick Ratio	3,36	3,34	3,96	4,98
Equity Ratio	0,62	0,62	0,67	0,7
Gross Profit Margin	85,45 %	93,5 %	92,62 %	86,89 %